Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 14, Issue 8, Pages 16617-16637
Publisher
MDPI AG
Online
2013-08-12
DOI
10.3390/ijms140816617
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current Treatment of Metastatic Endometrial Cancer
- (2017) Sarah M. Temkin et al. Cancer Control
- Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy
- (2013) Ayako Kitano et al. PLoS One
- Delineating a Conserved Genetic Cassette Promoting Outgrowth of Body Appendages
- (2013) Congxing Lin et al. PLoS Genetics
- An Emerging Strategy for Cancer Treatment Targeting Aberrant Glycogen Synthase Kinase 3β
- (2012) Katsuyoshi Miyashita et al. Anti-Cancer Agents in Medicinal Chemistry
- Reduced DICER1 Elicits an Interferon Response in Endometrial Cancer Cells
- (2012) K. B. Chiappinelli et al. MOLECULAR CANCER RESEARCH
- FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
- (2012) Sara A. Byron et al. PLoS One
- PIK3R1 (p85 ) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer
- (2011) M. E. Urick et al. CANCER RESEARCH
- A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
- (2011) Meghan L. Rudd et al. CLINICAL CANCER RESEARCH
- Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine
- (2011) Takeo Shimasaki et al. JOURNAL OF GASTROENTEROLOGY
- High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
- (2011) Lydia W.T. Cheung et al. Cancer Discovery
- Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy
- (2009) Shadi Mamaghani et al. BMC CANCER
- Potential Therapeutic Effect of Glycogen Synthase Kinase 3 Inhibition against Human Glioblastoma
- (2009) K. Miyashita et al. CLINICAL CANCER RESEARCH
- Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium
- (2009) A. J. Polotsky et al. HUMAN REPRODUCTION
- PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification
- (2009) Athanasia Spandidos et al. NUCLEIC ACIDS RESEARCH
- Knockin of mutant PIK3CA activates multiple oncogenic pathways
- (2009) John P. Gustin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GSK-3β Targets Cdc25A for Ubiquitin-Mediated Proteolysis, and GSK-3β Inactivation Correlates with Cdc25A Overproduction in Human Cancers
- (2008) Tiebang Kang et al. CANCER CELL
- Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy
- (2008) Zhong Wang et al. NATURE
- Drug-sensitive FGFR2 mutations in endometrial carcinoma
- (2008) A. Dutt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now